PubMed:10318905 / 1128-1361 JSONTXT

{"project":"PMID_GLOBAL","denotations":[{"id":"T13","span":{"begin":208,"end":223},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A13","pred":"mondo_id","subj":"T13","obj":"0008315"}],"text":"Together, these data provide a novel pathway from HER2/Neu to AR transactivation, and they may represent one of the reasons for the PSA re-elevation and hormone resistance during androgen ablation therapy in prostate cancer patients."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T7","span":{"begin":0,"end":233},"obj":"Sentence"},{"id":"T7","span":{"begin":0,"end":233},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Together, these data provide a novel pathway from HER2/Neu to AR transactivation, and they may represent one of the reasons for the PSA re-elevation and hormone resistance during androgen ablation therapy in prostate cancer patients."}

{"project":"DisGeNET5_gene_disease","denotations":[{"id":"10318905-6#132#135#gene354","span":{"begin":132,"end":135},"obj":"gene354"},{"id":"10318905-6#208#223#diseaseC0376358","span":{"begin":208,"end":223},"obj":"diseaseC0376358"},{"id":"10318905-6#208#223#diseaseC0600139","span":{"begin":208,"end":223},"obj":"diseaseC0600139"}],"relations":[{"id":"132#135#gene354208#223#diseaseC0376358","pred":"associated_with","subj":"10318905-6#132#135#gene354","obj":"10318905-6#208#223#diseaseC0376358"},{"id":"132#135#gene354208#223#diseaseC0600139","pred":"associated_with","subj":"10318905-6#132#135#gene354","obj":"10318905-6#208#223#diseaseC0600139"}],"text":"Together, these data provide a novel pathway from HER2/Neu to AR transactivation, and they may represent one of the reasons for the PSA re-elevation and hormone resistance during androgen ablation therapy in prostate cancer patients."}

{"project":"DisGeNet-2017-sample","denotations":[{"id":"T612","span":{"begin":132,"end":135},"obj":"gene:354"},{"id":"T613","span":{"begin":208,"end":223},"obj":"disease:C0376358"}],"relations":[{"id":"R11","pred":"associated_with","subj":"T612","obj":"T613"},{"id":"R12","pred":"associated_with","subj":"T612","obj":"T613"}],"namespaces":[{"prefix":"gene","uri":"http://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"disease","uri":"http://purl.bioontology.org/ontology/MEDLINEPLUS/"}],"text":"Together, these data provide a novel pathway from HER2/Neu to AR transactivation, and they may represent one of the reasons for the PSA re-elevation and hormone resistance during androgen ablation therapy in prostate cancer patients."}

{"project":"PubmedHPO","denotations":[{"id":"T10","span":{"begin":208,"end":223},"obj":"HP_0012125"},{"id":"T11","span":{"begin":217,"end":223},"obj":"HP_0002664"}],"text":"Together, these data provide a novel pathway from HER2/Neu to AR transactivation, and they may represent one of the reasons for the PSA re-elevation and hormone resistance during androgen ablation therapy in prostate cancer patients."}